| Model Number |
391239 |
| Medical Device Problem Code |
Material Deformation (2976)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
04/22/2021
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
Combination product: yes.
|
| |
|
Event or Problem Description
|
|
An orsiro drug-eluting stent system was selected for treatment of a severely calcified lesion (90 percent stenosis degree).After pre-dilatation the orsiro was delivered through a guideplus ii el (nipro) catheter, but could not cross the lesion.Then, the orsiro was removed from the patient and it was noticed that the stent edge was deformed.
|
| |
|
Additional Manufacturer Narrative
|
|
Combination product: yes.Only the stent was returned for investigation and subjected to a technical analysis.The production documentation was reviewed to establish whether a deviation from the manufacturing process could be the cause for this event.The technical investigation revealed that the stent has been inflated.The stent is slightly deformed at one end, i.E.Few struts are bent outwards.The delivery system was not returned for analysis.Review of the production documentation for the product detailed above verified that the instrument was manufactured according to specifications and fulfilled all the requirements of in-process and final inspection.During final inspection, every stent system undergoes visual inspection to ensure correct stent embedding and homogeneous crimping of the stent.Further, the stent outer diameter is verified to 100 percent.Based on the conducted investigations of the device being subject to this complaint, no material or manufacturing related root cause was determined.
|
| |
|
Search Alerts/Recalls
|